RETHINK RLS Trademark

Trademark Overview

On Wednesday, January 20, 2010, a trademark application was filed for RETHINK RLS with the United States Patent and Trademark Office. The USPTO has given the RETHINK RLS trademark a serial number of 77915986. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 4, 2013. This trademark is owned by Glaxo Group Limited. The RETHINK RLS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

medical and scientific research, namely, conducting clinical trials for pharmaceutical preparations for the treatment of restless leg syndrome
rethink rls

General Information

Serial Number77915986
Word MarkRETHINK RLS
Filing DateWednesday, January 20, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 4, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 1, 2010

Trademark Statements

Disclaimer with Predetermined Text"RLS"
Goods and Servicesmedical and scientific research, namely, conducting clinical trials for pharmaceutical preparations for the treatment of restless leg syndrome
Pseudo MarkRETHINK RESTLESS LEG SYNDROME

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 26, 2010
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB6ONN
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB6ONN
GB

Trademark Events

Event DateEvent Description
Monday, March 4, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, March 4, 2013ABANDONMENT - NO USE STATEMENT FILED
Saturday, July 28, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 27, 2012EXTENSION 4 GRANTED
Tuesday, July 24, 2012EXTENSION 4 FILED
Tuesday, July 24, 2012TEAS EXTENSION RECEIVED
Thursday, January 19, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 18, 2012EXTENSION 3 GRANTED
Tuesday, January 17, 2012EXTENSION 3 FILED
Tuesday, January 17, 2012TEAS EXTENSION RECEIVED
Thursday, July 28, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 27, 2011EXTENSION 2 GRANTED
Tuesday, July 26, 2011EXTENSION 2 FILED
Tuesday, July 26, 2011TEAS EXTENSION RECEIVED
Thursday, January 6, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 5, 2011EXTENSION 1 GRANTED
Tuesday, December 7, 2010EXTENSION 1 FILED
Wednesday, January 5, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 7, 2010TEAS EXTENSION RECEIVED
Tuesday, July 27, 2010NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 1, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 1, 2010PUBLISHED FOR OPPOSITION
Wednesday, May 12, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 29, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, April 29, 2010ASSIGNED TO LIE
Monday, April 19, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 19, 2010EXAMINER'S AMENDMENT ENTERED
Monday, April 19, 2010NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, April 19, 2010EXAMINERS AMENDMENT E-MAILED
Monday, April 19, 2010EXAMINERS AMENDMENT -WRITTEN
Monday, April 12, 2010ASSIGNED TO EXAMINER
Wednesday, January 27, 2010NOTICE OF PSEUDO MARK MAILED
Tuesday, January 26, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, January 23, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

rethink preparations pharmaceutical treatment restless syndrome trials clinical scientific research namely